<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical analysis of COVID-19 patients admitted to a hospital in Wuhan, China reported that patients showed elevated plasma concentrations of other cytokines including TNF-α, IL-7, IL1β, INFγ, IL1RA and MIP1A/B. Moreover, cytokine levels were higher in patients admitted to the intensive care unit (ICU) [
 <xref rid="B84-ijms-21-05559" ref-type="bibr">84</xref>]. Tumor necrosis factor-α (TNF-α) is an inflammatory cytokine secreted by activated monocyte/macrophages as part of innate immune system and is directly correlated with COVID-19 disease severity (
 <italic>R</italic> = −0.322, 
 <italic>p</italic> &lt; 0.001) [
 <xref rid="B85-ijms-21-05559" ref-type="bibr">85</xref>]. Although targeting TNF-α is rational and appealing, the clinical efficacy of anti-TNF antibodies (e.g., adalimumab) for SARS-CoV-2 infected patients needs further investigation [
 <xref rid="B86-ijms-21-05559" ref-type="bibr">86</xref>].
</p>
